Which laxative works best after pelvic surgery? new trial aims to find out

NCT ID NCT06335797

Recruiting now Symptom relief Sponsor: Wake Forest University Health Sciences Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This trial studies 88 women undergoing vaginal surgery for pelvic organ prolapse. Half will take senna pills and half will use bisacodyl suppositories after surgery. Researchers will measure how quickly each group has their first bowel movement and how satisfied they are with the treatment. The goal is to find the best way to prevent constipation after this type of surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: senna (Senokot) and bisacodyl (Dulcolax)
What this could lead to: If successful, this could identify which laxative works faster and is more satisfying for women recovering from pelvic surgery.
What could go wrong: This is a small, early-stage trial (88 participants) comparing two common laxatives, so results may not apply to all patients or surgeries. Neither laxative is a new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONSTIPATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pelvic organ prolapse constipation disorder prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CONSTIPATION

Contacts and locations

Locations

Wake Forest University Health Sciences
RECRUITING

Winston-Salem, North Carolina, 27157, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.